|
Volumn 85, Issue 1, 2001, Pages 26-28
|
Congenital adrenal hyperplasia: management during critical illness.
a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIINFLAMMATORY AGENT;
HYDROCORTISONE;
ADOLESCENT;
ARTICLE;
BLOOD;
CHILD;
CONGENITAL ADRENAL HYPERPLASIA;
CRITICAL ILLNESS;
FEMALE;
HALF LIFE TIME;
HUMAN;
INTRAVENOUS DRUG ADMINISTRATION;
MALE;
PRESCHOOL CHILD;
PROSPECTIVE STUDY;
STATISTICAL MODEL;
ADOLESCENT;
ADRENAL HYPERPLASIA, CONGENITAL;
ANTI-INFLAMMATORY AGENTS;
CHILD;
CHILD, PRESCHOOL;
CRITICAL ILLNESS;
FEMALE;
HALF-LIFE;
HUMANS;
HYDROCORTISONE;
INJECTIONS, INTRAVENOUS;
LINEAR MODELS;
MALE;
PROSPECTIVE STUDIES;
MLCS;
MLOWN;
|
EID: 0035403903
PISSN: None
EISSN: 14682044
Source Type: Journal
DOI: 10.1136/adc.85.1.26 Document Type: Article |
Times cited : (24)
|
References (0)
|